PuSH - Publikationsserver des Helmholtz Zentrums München

81 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Effner, R. et al.: Effects of environmental signaling in patients with STAT1/STAT3-dependent primary immunodeficiencies. Exp. Dermatol. 28, E70-E70 (2019)
2.
Ranzinger, D.L.* et al.: IL23 differentially regulates cytokine profile of Th17 subsets leading to deviation of protective and pathogenic Th17 cells. Exp. Dermatol. 28, E38-E38 (2019)
3.
Thomas, J. et al.: Is the humoral immunity dispensable for the pathogenesis of psoriasis? J. Eur. Acad. Dermatol. Venereol. 33, 115-122 (2019)
4.
Thomas, J. et al.: Foxo4 and AHR control a stress-induced immune-mediated host protection via secretion of IL-22. Exp. Dermatol. 28, E76-E77 (2019)
5.
Wang, R.* et al.: CD23 is a biomarker of clinical response to IgE-specific immunoadsorption in patients with severe atopic eczema. Exp. Dermatol. 28, E29-E30 (2019)
6.
Baghin, V.* et al.: Predictive models for the natural course of atopic dermatitis in childhood based on serum parameters and clinical attributes. Exp. Dermatol. 27, E17-E17 (2018)
7.
Effner, R.* et al.: Xenobiotic metabolism in STAT1-imbalanced patients with chronic mucocutaneous candidiasis. Allergy 73, 309-309 (2018)
8.
Eyerich, K.* & Eyerich, S.: Immune response patterns in chronic inflammatory skin diseases a basis of targeted therapy. J. Invest. Dermatol. 138, S16-S16 (2018)
9.
Eyerich, S. ; Eyerich, K.* ; Traidl-Hoffmann, C. & Biedermann, T.*: Cutaneous barriers and skin immunity: Differentiating a connected network. Trends Immunol. 39, 315-327 (2018)
10.
Frey, K.* ; Lauffer, F.* ; Garzorz-Stark, N.* ; Eyerich, S. & Eyerich, K.*: Mapping of disease severity in patients with systemic sclerosis. Science 27, E23-E23 (2018)
11.
Frey, K.M.* ; Lauffer, F.* ; Garzorz-Stark, N.* ; Eyerich, S. & Eyerich, K.: Mapping of disease severity in patients with scleroderma. Allergy 73, 730-730 (2018)
12.
Garzorz-Stark, N.* et al.: Toll-like receptor 7/8 agonists stimulate plasmacytoid dendritic cells to initiate T(H)17-deviated acute contact dermatitis in human subjects. J. Allergy Clin. Immunol. 141, 1320-1333.e11 (2018)
13.
Garzorz-Stark, N.* et al.: The relevance of CMV reactivation in immunocompromised patients suffering from chronic inflammatory skin diseases. Biodegradation 138, S170-S170 (2018)
14.
Hiller, J. et al.: STAT1 gain-of-function and dominant negative STAT3 mutations impair IL-17 and IL-22 immunity associated with CMC. J. Invest. Dermatol. 138, 711-714 (2018)
15.
Hiller, J. et al.: STAT1/STAT3 imbalance determines the clinical phenotype of chronic mucocutaneous candidiasis. Science 27, E49-E50 (2018)
16.
Jargosch, M.* et al.: Necroptosis as special type of cell death in inflammatory skin diseases. J. Invest. Dermatol. 138, S116-S116 (2018)
17.
Jargosch, M.* et al.: Necroptosis as special type of cell death in inflammatory skin diseases. Allergy 73, 731-731 (2018)
18.
Krause, L. et al.: Mathematical concepts and their challenges in predicting severity of atopic eczema patients. Allergy 73, 731-731 (2018)
19.
Lauffer, F.* et al.: Type I immune response induces keratinocyte necroptosis and is associated with interface dermatitis. J. Invest. Dermatol., accepted (2018)
20.
Lauffer, F.* et al.: IL-17C: Checkpoint in innate skin immunology. Science 27, E55-E55 (2018)